Medplus Health's Share Allotment To Take Place Tomorrow
Pharmacy retailer Medplus Health's share allotment will take place tomorrow on December 20. The public issue, which was worth Rs 1,398 crore, was subscribed 52.59 times, when it had opened between December 13 and 15, 2021.
Its retail portion was subscribed 5.24 times and according to market observers, in the grey market, Medplus Health's shares are currently trading at a premium of Rs 250.
Investors keen to know the status of share allotment of Medplus Health can do so by either visiting the Bombay stock exchange (BSE) website or that of the official registrar of the IPO, KFintech IPO.
On the BSE website, Medplus Health's share allotment status can be checked by following the below mentioned steps:
Login at the direct link to BSE website — bseindia.com/investors/appli_check.aspx. Once this is done, select Medplus Health IPO and enter the Medplus Health IPO application number.
After this, the subscriber has to enter the PAN details and then click on the "I am not a robot" button. After doing so, the "submit" button needs to be clicked and the allotment status will appear on the screen.
Medplus Health's share allotment status can also be checked on the official registrar KFintech IPO's website, which is kprism.kfintech.com/ipostatus.
The subscribers need to first log in on the above mentioned link and select Medplus Health IPO. After this, one needs to either select "Appliction Number or PAN.
Once this is done, enter the Medplus Health IPO application number, fill Captcha and click on the "Submit" button. The status will appear on the screen.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
-
Navigating Energy Crossroads: S Jaishankar's Call For Diversified Supply Chains At G20 Ministerial Meeting
As geopolitical fault lines continue to test maritime trade routes and commodity flows, Jaishankar's message remains pertinent: true economic resilience requires open markets, protected transit lines, and a genuine commitment to multilateral cooperation rather than coercion.
-
Indians Are Travelling, But Not Every Journey Is A Holiday | The Week In Whys
Pilgrims, patients and working women are the real travellers, and the system hasn't quite caught up with them.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
